Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$561M |
| 2 |
Citizens Financial Group
CFG
|
+$465M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$462M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$439M |
| 5 |
WEC Energy
WEC
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$1.33B |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1B |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$968M |
| 4 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$740M |
| 5 |
Wells Fargo
WFC
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.24% |
| 2 | Financials | 14.23% |
| 3 | Technology | 13.63% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Discretionary | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Citizens
CIA
$231M
| $9.92M | ﹤0.01% |
1,329,915
+39,127
| +3% | +$245K |
|
|
CPRX
2677
DELISTED
Catalyst Pharmaceutical
CPRX
| $9.9M | ﹤0.01% |
2,397,138
+168,549
| +8% | +$672K |
|
2678
Braskem
BAK
$928M
| $9.89M | ﹤0.01% |
1,142,632
-682
| -0.1% | -$5.82K |
|
|
RGLS
2679
DELISTED
Regulus Therapeutics
RGLS
| $9.89M | ﹤0.01% |
7,519
+463
| +7% | +$747K |
|
|
MLNX
2680
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $9.88M | ﹤0.01% |
203,430
+121,584
| +149% | +$5.9M |
|
|
PHIIK
2681
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $9.76M | ﹤0.01% |
325,257
+5,999
| +2% | +$197K |
|
|
ATRS
2682
DELISTED
Antares Pharma, Inc.
ATRS
| $9.74M | ﹤0.01% |
4,682,968
+426,536
| +10% | +$1.03M |
|
|
ZVO
2683
DELISTED
Zovio Inc. Common Stock
ZVO
| $9.73M | ﹤0.01% |
1,018,219
+37,613
| +4% | +$357K |
|
|
CBR
2684
DELISTED
CIBER Inc.
CBR
| $9.73M | ﹤0.01% |
2,820,476
+32,955
| +1% | +$120K |
|
|
NEWR
2685
DELISTED
New Relic, Inc.
NEWR
| $9.7M | ﹤0.01% |
275,723
-110,275
| -29% | -$3.6M |
|
|
ANTH
2686
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $9.65M | ﹤0.01% |
139,995
+8,185
| +6% | +$379K |
|
|
HDP
2687
DELISTED
Hortonworks, Inc.
HDP
| $9.64M | ﹤0.01% |
380,839
+102,073
| +37% | +$2.45M |
|
2688
eHealth
EHTH
$42.9M
| $9.64M | ﹤0.01% |
759,662
+4,615
| +0.6% | +$55.8K |
|
2689
Par Pacific Holdings
PARR
$3.46B
| $9.62M | ﹤0.01% |
514,106
+51,223
| +11% | +$1.18M |
|
|
GCAP
2690
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $9.59M | ﹤0.01% |
1,003,479
+381,894
| +61% | +$3.74M |
|
2691
CRA International
CRAI
$1.14B
| $9.56M | ﹤0.01% |
343,170
-6,777
| -2% | -$198K |
|
|
DSPG
2692
DELISTED
DSP Group Inc
DSPG
| $9.55M | ﹤0.01% |
924,696
+12,380
| +1% | +$140K |
|
|
RCAP
2693
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
| $9.54M | ﹤0.01% |
1,245,746
+122,217
| +11% | +$992K |
|
2694
Vitamin Cottage Natural Grocers
NGVC
$748M
| $9.51M | ﹤0.01% |
386,141
+17,885
| +5% | +$458K |
|
2695
Barrett Business Services
BBSI
$813M
| $9.48M | ﹤0.01% |
1,043,848
+16,804
| +2% | +$170K |
|
2696
Peapack-Gladstone Financial
PGC
$815M
| $9.48M | ﹤0.01% |
426,481
+7,662
| +2% | +$161K |
|
2697
Vicor
VICR
$10.1B
| $9.47M | ﹤0.01% |
777,298
+13,660
| +2% | +$200K |
|
|
PSTB
2698
DELISTED
Park Sterling Corp.
PSTB
| $9.47M | ﹤0.01% |
1,314,780
+10,966
| +0.8% | +$76K |
|
2699
Ducommun
DCO
$3.04B
| $9.46M | ﹤0.01% |
368,711
+3,446
| +0.9% | +$92.6K |
|
|
ENOC
2700
DELISTED
EnerNOC, Inc.
ENOC
| $9.46M | ﹤0.01% |
975,273
+25,680
| +3% | +$276K |
|
Similar funds
Vanguard Group's Q2 2015 Portfolio in Review
As of Q2 2015, Vanguard Group held 4,259 positions worth $1.48T, up 0.33% from $1.47T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q2 2015: portfolio turnover was 4%. Vanguard Group opened 105 new positions and exited 67, leaving the 4,259-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- Vanguard Group's largest Q2 2015 buy was Uniti Group: 7,979,038 shares worth $197M.
- Vanguard Group added most to AbbVie in Q2 2015, an estimated $561M increase.
- Vanguard Group's biggest Q2 2015 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $968M.
- Vanguard Group fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $1.33B.
- Vanguard Group's ten largest holdings make up 13% of its $1.48T portfolio in Q2 2015.
- Vanguard Group opened 105 new positions and closed 67 in Q2 2015.
- Vanguard Group's portfolio value rose 0.33% quarter-over-quarter to $1.48T.
Based on Vanguard Group's 13F filing for Q2 2015, filed 13 Aug 2015.